Engineers Gate Manager LP Nurix Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $4.86 Billion
- Q3 2024
A detailed history of Engineers Gate Manager LP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 24,975 shares of NRIX stock, worth $464,285. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,975
Previous 24,552
1.72%
Holding current value
$464,285
Previous $512,000
9.38%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
178Shares Held
67.6MCall Options Held
78KPut Options Held
53.8K-
Black Rock Inc. New York, NY6.82MShares$127 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.28MShares$79.6 Million6.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$74.6 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$72.2 Million0.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.87MShares$71.9 Million3.2% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $876M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...